91 related articles for article (PubMed ID: 19264376)
1. Potent inhibition of OKT3-induced T cell proliferation and suppression of CD147 cell surface expression in HeLa cells by scFv-M6-1B9.
Intasai N; Tragoolpua K; Pingmuang P; Khunkaewla P; Moonsom S; Kasinrerk W; Lieber A; Tayapiwatana C
Immunobiology; 2008; 214(6):410-21. PubMed ID: 19264376
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Extracellular Matrix Metalloproteinase Inducer by scFv-M6-1B9 Intrabody Suppresses Cervical Cancer Invasion Through Inhibition of Urokinase-Type Plasminogen Activator.
Panich T; Tragoolpua K; Pata S; Tayapiwatana C; Intasai N
Cancer Biother Radiopharm; 2017 Feb; 32(1):1-8. PubMed ID: 28118037
[TBL] [Abstract][Full Text] [Related]
3. Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cells.
Tragoolpua K; Intasai N; Kasinrerk W; Mai S; Yuan Y; Tayapiwatana C
BMC Biotechnol; 2008 Jan; 8():5. PubMed ID: 18226275
[TBL] [Abstract][Full Text] [Related]
4. CD147 contains different bioactive epitopes involving the regulation of cell adhesion and lymphocyte activation.
Chiampanichayakul S; Peng-in P; Khunkaewla P; Stockinger H; Kasinrerk W
Immunobiology; 2006; 211(3):167-78. PubMed ID: 16530084
[TBL] [Abstract][Full Text] [Related]
5. EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.
Sangboonruang S; Thammasit P; Intasai N; Kasinrerk W; Tayapiwatana C; Tragoolpua K
Cancer Gene Ther; 2014 Jun; 21(6):246-55. PubMed ID: 24924201
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of humanized single-chain variable fragment against its functional epitope on domain 1 of CD147.
Intasai N; Rangnoi K; Yamabhai M; Pamonsupornwichit T; Thongkum W; Yasamut U; Chupradit K; Takheaw N; Nimmanpipug P; Tayapiwatana C
Sci Rep; 2022 Apr; 12(1):6719. PubMed ID: 35468972
[TBL] [Abstract][Full Text] [Related]
7. Baculovirus display of single chain antibody (scFv) using a novel signal peptide.
Kitidee K; Nangola S; Gonzalez G; Boulanger P; Tayapiwatana C; Hong SS
BMC Biotechnol; 2010 Nov; 10():80. PubMed ID: 21092083
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody.
Thammasit P; Sangboonruang S; Suwanpairoj S; Khamaikawin W; Intasai N; Kasinrerk W; Tayapiwatana C; Tragoolpua K
J Cancer; 2015; 6(3):276-86. PubMed ID: 25663946
[TBL] [Abstract][Full Text] [Related]
9. CD147 and CD98 complex-mediated homotypic aggregation attenuates the CypA-induced chemotactic effect on Jurkat T cells.
Guo N; Zhang K; Lv M; Miao J; Chen Z; Zhu P
Mol Immunol; 2015 Feb; 63(2):253-63. PubMed ID: 25089027
[TBL] [Abstract][Full Text] [Related]
10. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
Baba M; Inoue M; Itoh K; Nishizawa Y
Biochem Biophys Res Commun; 2008 Sep; 374(1):111-6. PubMed ID: 18616931
[TBL] [Abstract][Full Text] [Related]
11. Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets.
Pata S; Surinkaew S; Takheaw N; Laopajon W; Chuensirikulchai K; Kasinrerk W
Front Immunol; 2021; 12():704309. PubMed ID: 34421910
[TBL] [Abstract][Full Text] [Related]
12. Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization.
Zhu X; Wang D; Li S; Xiao Q; Tao K; Hu J; Cao W; Feng W
Int J Mol Med; 2012 May; 29(5):939-45. PubMed ID: 22322313
[TBL] [Abstract][Full Text] [Related]
13. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line.
Chen X; Su J; Chang J; Kanekura T; Li J; Kuang YH; Peng S; Yang F; Lu H; Zhang JL
Cancer Invest; 2008 Aug; 26(7):689-97. PubMed ID: 18608214
[TBL] [Abstract][Full Text] [Related]
15. Reduction of CD147 surface expression on primary T cells leads to enhanced cell proliferation.
Biegler B; Kasinrerk W
Asian Pac J Allergy Immunol; 2012 Dec; 30(4):259-67. PubMed ID: 23393905
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma.
Zou J; Chen D; Zong Y; Ye S; Tang J; Meng H; An G; Zhang X; Yang L
Cancer Sci; 2015 May; 106(5):512-21. PubMed ID: 25664501
[TBL] [Abstract][Full Text] [Related]
17. Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.
Pistol G; Matache C; Calugaru A; Stavaru C; Tanaseanu S; Ionescu R; Dumitrache S; Stefanescu M
J Cell Mol Med; 2007; 11(2):339-48. PubMed ID: 17488482
[TBL] [Abstract][Full Text] [Related]
18. Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147.
Knutti N; Kuepper M; Friedrich K
FEBS J; 2015 Nov; 282(21):4187-200. PubMed ID: 26277583
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CD147 isoform‑4 in the proliferation of SiHa cells: a possible molecular mechanism of cervical cancer.
Wu Y; Zhou X; Zheng PS
Oncol Rep; 2011 Sep; 26(3):717-24. PubMed ID: 21687950
[TBL] [Abstract][Full Text] [Related]
20. An efficient method for refolding the extracellular portion of CD147 from the total bacterial lysate.
Song F; Zhang X; Li Y; Ru Q; Ren X; Xia B; Chen ZN
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):900-8. PubMed ID: 21764804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
